Announces Closing of Non-Brokered Private Placement Offering of Units and Debt Settlement
Summary
Depending on market and other conditions, Nova may from time to time in the future increase or decrease the ownership, control or direction over securities of the Company, through market transactions, private agreements, or otherwise.In satisfaction of the requirements of Multilateral Instrument 62-104 Take-Over Bids and Issuer Bids and National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, an early warning report regarding the acquisition of securities by Nova will be filed under the Companys SEDAR+ Profile at www.sedarplus.ca. The Company is located in 65 International Blvd, Suite 103, Etobicoke, Ontario, M9W 6L9, CanadaSUBSCRIBE: For more information on Glow or to subscribe to the Companys mail list visit: https://www.glowlifetech.com/newsAbout Glow LifeTech Corp. Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has rights to the groundbreaking, plant-based MyCell Technology\xae delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.Except for statements of historic fact, this news release contains certain forward-looking information within the meaning of applicable securities law. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or managements estimates or opinions should change except as required by law.